Bayer launches Supradyn in Kenya to boost nutritional wellness

KENYA – Bayer East Africa’s Consumer Health Division has officially introduced its Supradyn brand in Kenya, unveiling two new multivitamin products—Supradyn Immuno Triple Action and Supradyn Boost.

Designed to supplement daily vitamin and mineral intake, these products aim to address nutritional gaps and support healthier lifestyles for a diverse consumer base, including upwardly mobile urban professionals, families, and fitness enthusiasts.

At the launch event in Nairobi, Ms. Nompumelelo Thwala, Senior Brand Manager for Southern East Africa at Bayer Consumer Health, emphasized that the Supradyn introduction responds to the growing demand for self-care solutions in Kenya.

“Our goal is to address the evolving health needs of consumers by offering them trusted options for meeting their nutritional and wellness goals,” she said.

This strategic move is poised to help Kenyans maintain optimal health amid rising healthcare costs and an increasingly health-conscious society.

Bayer’s launch is supported by a robust 12-month consumer awareness campaign titled ‘Go Beyond,’ which will be activated in shopping malls and retail outlets throughout Nairobi and other urban centers.

The campaign will leverage digital media and e-commerce platforms to boost product awareness, consumer engagement, and ultimately drive sales.

By combining traditional and digital marketing strategies, Bayer aims to reach a broad audience, ensuring that Supradyn becomes a household name in nutritional supplementation across Kenya.

The demand for multivitamins in Kenya is surging due to multiple factors. A growing awareness of health and wellness, coupled with the rising cost of healthcare, is driving consumers toward preventive supplements.

Additionally, the increasing penetration of e-commerce in the region has made dietary supplements more accessible, encouraging more Kenyans to seek affordable and effective nutritional solutions.

Studies indicate that common micronutrient deficiencies in Kenya include iron, vitamin A, and zinc—deficiencies that Supradyn products are well-positioned to address.

Market projections for Kenya’s Vitamins & Minerals sector are robust, with revenues expected to reach US$193.57 million in 2025 and an annual growth rate of 7.64% from 2025 to 2029.

With a per capita expenditure of approximately US$3.38 in this market in 2025, the launch of Supradyn aligns perfectly with the country’s evolving consumer needs and the broader trend towards proactive health management.

Beyond its role in promoting individual health, the Supradyn launch also holds significant implications for public health in Kenya.

With more than 3.4 million Kenyans experiencing food insecurity and over 400,000 children under five suffering from malnutrition, there is a critical need for nutritional support.

Bayer’s initiative is expected to complement ongoing efforts by government and non-governmental organizations, such as UNICEF, which are actively working to improve nutrition and reduce malnutrition rates among vulnerable populations.